Growth Disorder Clinical Trial
Official title:
Phase III Study of Humatrope in Non-Growth Hormone Deficient Children With Short Stature
After approval of amendment (g), patients who were still receiving study drug at the time
were scheduled for a study visit. In addition, patients who had discontinued early from the
core, blinded phase of the study were contacted.
All of these patients were offered the opportunity to enter the unblinded extension phase
(if they met eligibility criteria) and continue somatropin treatment (regardless of initial
treatment randomization) until they reached final height.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01943084 -
A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects
|
Phase 1 | |
| Completed |
NCT02580032 -
Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)
|
||
| Completed |
NCT00001190 -
Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature
|
Phase 2 | |
| Completed |
NCT01578135 -
French National Registry of Children Born Small for Gestational Age Treated With Somatropin
|
||
| Completed |
NCT01401244 -
Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers
|
Phase 1 | |
| Recruiting |
NCT02769975 -
Evaluation of Children With Endocrine and Metabolic-Related Conditions
|
||
| Completed |
NCT01778023 -
Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature
|
Phase 3 | |
| Completed |
NCT01543867 -
Safety and Efficacy of Long-term Somatropin Treatment in Children
|
N/A | |
| Terminated |
NCT02311322 -
Genetic Causes of Growth Disorders
|
||
| Withdrawn |
NCT01512095 -
Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers
|
Phase 1 | |
| Completed |
NCT00262249 -
Effect of Growth Hormone in Children With Growth Hormone Deficiency
|
Phase 3 | |
| Completed |
NCT02428296 -
Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation
|
Phase 2 | |
| Completed |
NCT00174421 -
Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height
|
Phase 3 |